Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Dec 17;540(1):240–251. doi: 10.1111/j.1749-6632.1988.tb27066.x

Mechanisms of Virus‐Induced Demyelination and Remyelinationa

MOSES RODRIGUEZ 1
PMCID: PMC7167894  PMID: 3061337

The content is available as a PDF (785.1 KB).

a

This work was supported in part by grants from the National Multiple Sclerosis Society (RG 1878‐A1) and Searle Foundation. Moses Rodriguez is the recipient of a Teacher Investigator Award (NS‐00849) from the National Institutes of Health.

References

  • 1. Dal Canto, M. C. & Rabinowitz S. G.. 1982. Experimental models of virus‐induced demyelination of the central nervous system. Ann. Neurol. 11: 109–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Lampert, P. W. , Sims K. J. & Kniazeff A. J.. 1973. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol. (Berl.) 24: 76–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Weiner, L. P. 1973. Pathogenesis of demyelination induced by a mouse hepatitis virus. Arch. Neurol. 28: 298–303. [DOI] [PubMed] [Google Scholar]
  • 4. Powell, H. C. & Lampert P. W.. 1975. Oligodendrocytes and their myelin‐plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab. Invest. 33: 440–445. [PubMed] [Google Scholar]
  • 5. Herndon, R. M. , Price D. L. & Weiner L. P.. 1977. Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693–694. [DOI] [PubMed] [Google Scholar]
  • 6. Knobler, R. L. , Haspel M. V. & Oldstone M. B. A.. 1981. Mouse hepatitis virus type 4 (JHM strain)‐induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. J. Exp. Med. 153: 832–843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Richardson, E. P. 1961. Progressive multifocal leukoencephalopathy. N. Engl. J. Med. 265: 815–823. [DOI] [PubMed] [Google Scholar]
  • 8. Zu Rhein, G. M. & Chou S. M.. 1965. Particles resembling papova viruses in human cerebral demyelinating disease. Science 148: 1477–1479. [DOI] [PubMed] [Google Scholar]
  • 9. Krupp, L. B. , Lipton R. B., Swerdlow M. L., Leeds N. E. & Llena J.. 1985. Progressive multifocal leukoencephalopathy. Clinical and radiographie features. Ann. Neurol. 17: 344–349. [DOI] [PubMed] [Google Scholar]
  • 10. Aksamit, A. J. , Mourrain P., Sever J. L. & Major E. O.. 1985. Progressive multifocal leokoencephalopathy. Investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann. Neurol. 18: 490–496. [DOI] [PubMed] [Google Scholar]
  • 11. Lampert, P. W. 1978. Autoimmune and virus‐induced demyelinating diseases: A review. Am. J. Pathol. 91: 176–208. [PMC free article] [PubMed] [Google Scholar]
  • 12. Nagashima, K. , Wege H., Meyermann R. & Ter Meulen V.. 1979. Demyelinating encephalomyelitis induced by a long‐term corona virus infection in rats: A preliminary report. Acta. Neuropathol (Berl.) 45: 205–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Watanabe, R. , Wege H. & Ter Meulen V.. 1983. Adoptive transfer of EAE‐like lesions from rats with coronavirus‐induced demyelinating encephalomyelitis. Nature 305: 150–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Theiler, M. 1934. Spontaneous encephalomyelitis of mice: A new virus disease. Science 80: 122. [DOI] [PubMed] [Google Scholar]
  • 15. Lipton, H. L. 1975. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect. Immunol. 11: 1147–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Barbano, R. L. & Dal Canto M. C.. 1984. Serum and cells from Theiler's virus‐infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease: The pathogenesis of Theiler's virus‐induced demyelination appears to differ from that of EAE. J. Neurol. Sci. 66: 283–293. [DOI] [PubMed] [Google Scholar]
  • 17. Lampert, P. W. , Fujinami R. S., Rodriguez M., Leibowitz J. L. & Lang W.. 1983. Further studies on the pathogenesis of Theiler's murine encephalomyelitis (abstract). J. Neuropathol. Exp. Neurol. 42: 326. [Google Scholar]
  • 18. Miller, S. D. , Clatch R. J., Pevear D. C., Trotter J. L. & Lipton H. L.. 1987. Class II‐restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease. I. Cross‐specificity among TMEV substrains and related picornaviruses but not myelin proteins. J. Immunol. 138: 3776–3784. [PubMed] [Google Scholar]
  • 18a. Rodriguez, M. , Lucchinetti C. F., Clark R. J., Yaksh T. L., Markowitz H. & Lennon V. A.. 1988. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J. Immunol. 140: 800–805. [PubMed] [Google Scholar]
  • 19. McCullough, B. , Krakowka S. & Koestner A.. 1974. Experimental canine distemper virus‐induced demyelination. Lab. Invest. 31: 216–222. [PubMed] [Google Scholar]
  • 20. Krakowka, S. , McCullough B., Koestner A. & Olsen R.. 1973. Myelin specific autoantibodies associated with central nervous system demyelination in canine distemper virus infection. Infect. Immunol. 8: 819–827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Wisniewski, H. M. & Bloom B. R.. 1975. Primary demyelination as a non‐specific consequence of a cell‐mediated reaction. J. Exp. Med. 141: 346–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Cammer, W. , Bloom B. R., Norton W. T. & Gordon S.. 1978. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA 75: 1554–1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Powell, H. C. , Braheny S. L., Hughes R. A. C. & Lampert P. W.. 1984. Antigenspecific demyelination and significance of the bystander effect in peripheral nerves. Am. J. Pathol. 114: 443–453. [PMC free article] [PubMed] [Google Scholar]
  • 24. Clatch, R. J. , Lipton H. L. & Miller S. D.. 1986. Characterization of Theiler's murine encephalomyelitis virus (TMEV)‐specific delayed type hypersensitivity responses in TMEV‐induced demyelinating disease: Correlation with clinical signs. J. Immunol. 136: 920–927. [PubMed] [Google Scholar]
  • 25. Dal Canto, M. C. & Lipton H. L.. 1982. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106: 20–29. [PMC free article] [PubMed] [Google Scholar]
  • 26. Lipton, H. L. & Melvold R.. 1984. Genetic analysis of susceptibility to Theiler's virusinduced demyelinating disease in mice. J. Immunol. 132: 1821–1825. [PubMed] [Google Scholar]
  • 27. Clatch, R. J. , Melvold R. W., Miller S. D. & Lipton H. L.. 1985. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H‐2D region: Correlation with TMEV‐specific delayed‐type hypersensitivity. J. Immunol. 135: 1408–1414. [PubMed] [Google Scholar]
  • 28. Rodriguez, M. & David C. S.. 1985. Demyelination induced by Theiler's virus: Influence of the H‐2 haplotype. J. Immunol. 135: 2145–2148. [PubMed] [Google Scholar]
  • 29. Rodriguez, M. , Leibowitz J. & David C. S.. 1986. Susceptibility to Theiler's virusinduced demyelination: Mapping of the gene within the H‐2D region. J. Exp. Med. 163: 620–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Rodriguez, M. & Quddus J.. 1986. Effect of cyclosporin A, silica quartz dust and protease inhibitors on virus‐induced demyelination. J. Neuroimmunol. 13: 159–174. [DOI] [PubMed] [Google Scholar]
  • 31. Roos, R. P. & Wollmann R.. 1984. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15: 494–499. [DOI] [PubMed] [Google Scholar]
  • 32. Rosenthal, A. , Fujinami R. S. & Lampert P. W.. 1986. Mechanism of Theiler's virusinduced demyelination in nude mice. Lab. Invest. 54: 515–522. [PubMed] [Google Scholar]
  • 33. Rodriguez, M. & Sriram S.. 1987. Treatment of TMEV‐induced demyelination with monoclonal antibodies to T cell subsets (abstract). Neurology 37(Suppl. 1): 344. [Google Scholar]
  • 34. Lampert, P. W. & Rodriguez M.. 1984. Virus‐induced demyelination In Viral Pathogenesis, Vol. 1: 260–268. Notkins A. L. & Oldstone M. B. A., Eds. Springer‐Verlag. New York . [Google Scholar]
  • 35. Nitayaphan, S. , Toth M. M. & Roos R. P.. 1985. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses. J. Virol. 56: 887–895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Nitayaphan, S. , Toth M. M. & Roos R. P.. 1985. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J. Virol. 53: 651–657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Sigurdsson, B. 1954. Rida, a chronic encephalitis of sheep. Br. Vet. J. 110: 341–354. [Google Scholar]
  • 38. Petursson, G. , Nathanson N., Georgsson G., Panitch H. & Palsson P. A.. 1976. Pathogenesis of visna. I. Sequential virologie, serologic, and pathologic studies. Lab. Invest. 35: 402–412. [PubMed] [Google Scholar]
  • 39. Narayan, O. , Griffin D. E. & Chase J.. 1977. Antigenic drift of visna virus in persistently infected sheep. Science 197: 376–378. [DOI] [PubMed] [Google Scholar]
  • 40. Rodriguez, M. , Pease L. R. & David C. S.. 1986. Immune‐mediated injury of virusinfected oligodendrocyte: A model of multiple sclerosis. Immunol. Today 7: 359–363. [DOI] [PubMed] [Google Scholar]
  • 41. Lampert, P. W. , Joseph B. S. & Oldstone M. B. A.. 1976. Morphological changes of cells infected with measles or related to viruses In Progress in Neuropathology, Vol. 3: 51–68. Zimmerman H. M., Ed. Grune and Stratton. New York . [Google Scholar]
  • 42. Dal. Canto, M. C. & Lipton H. L.. 1975. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 33: 626–637. [PubMed] [Google Scholar]
  • 43. Lindsley, M. D. & Rodriguez M.. 1987. Isolation of inflammatory cells from the CNS of mice persistently infected with Theiler's virus (abstract). J. Neuropathol. Exp. Neurol. 46: 369. [Google Scholar]
  • 44. Lipton, H. L. & Dal Canto M. C.. 1976. Theiler's virus‐induced demyelination: Prevention by immunosuppression. Science 192: 62–64. [DOI] [PubMed] [Google Scholar]
  • 45. Roos, R. P. , Firestone S., Wollman R., Variakojis P. & Arnason B. G. W.. 1982. The effect of short‐term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2: 223–234. [DOI] [PubMed] [Google Scholar]
  • 46. Rodriguez, M. , Lafuse W. P., Leibowitz J. & David C. S.. 1986. Partial suppression of Theiler's virus‐induced demyelination in vivo by administration of monoclonal antibodies to immune response gene products (Ia antigens). Neurology 36: 964–970. [DOI] [PubMed] [Google Scholar]
  • 47. Friedman, A. , Frankel G., Lorch Y. & Steinman L.. 1987. Monoclonal anti‐I‐A antibody reverses chronic paralysis and demyelination in Theiler's virus‐infected mice: Critical importance of timing of treatment. J. Virol. 61: 898–903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Rodriguez, M. , Pierce M. L. & Howie E. A.. 1987. Immune response gene products (Ia antigens) on glial and endothelial cells in virus‐induced demyelination. J. Immunol. 138: 3438–3442. [PubMed] [Google Scholar]
  • 49. Rodriguez, M. , Leibowitz J. L. & Lampert P. W.. 1983. Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis. Ann. Neurol. 13: 426–433. [DOI] [PubMed] [Google Scholar]
  • 50. Rodriguez, M. 1985. Virus‐induced demyelination in mice: “Dying back” of oligodendrocytes. Mayo Clin. Proc. 60: 433–438. [DOI] [PubMed] [Google Scholar]
  • 51. Penney, J. B., Jr. & Wolinsky J. S.. 1979. Neuronal and oligodendroglial infection by the WW strain of Theiler's virus. Lab. Invest. 40: 324–330. [PubMed] [Google Scholar]
  • 52. Wroblewska, Z. , Kim S. U., Sheffield W. D. & Gilden D. H.. 1979. Growth of the WW strain of Theiler's virus in mouse central nervous system organotypic culture. Acta. Neuropathol. (Berl.) 47: 13–19. [DOI] [PubMed] [Google Scholar]
  • 53. Graves, M. C. , Bologa L., Siegel L. & Londe H.. 1986. Theiler's virus in brain cell cultures: Lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J. Neurosci. Res. 15: 491–501. [DOI] [PubMed] [Google Scholar]
  • 54. Rodriguez, M. , Hovanec‐Burns D., Siegel L. & Graves M.. 1986. Cultured glial cells express Theiler's virus‐associated antigen on their surfaces (abstract). Ann. Neurol. 20: 143. [DOI] [PubMed] [Google Scholar]
  • 55. Brahic, M. , Stroop W. G. & Baringer J. R.. 1981. Theiler's virus persists in glial cells during demyelinating disease. Cell 26: 123–128. [DOI] [PubMed] [Google Scholar]
  • 56. Chamorro, M. , Aubert C. & Brahic M.. 1986. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. J. Virol. 57: 992–997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Aubert, C. , Chamorro M. & Brahic M.. 1987. Identification of Theiler's virus infected cells in the central nervous system of mice during demyelinating disease. Microbiol. Pathogen. 31: 319–326. [DOI] [PubMed] [Google Scholar]
  • 58. Ludwin, S. K. 1981. Pathology of demyelination and remyelination InWaxman S. G. & Ritchie J. M., Eds. Demyelinating Diseases: Basic and Clinical Electrophysiology. Advances in Neurology, Vol. 31: 123–168. Raven Press, New York . [PubMed] [Google Scholar]
  • 59. Lang, W. , Rodriguez M., Lennon V. A. & Lampert P. W.. 1984. Demyelination and remyelination in murine viral encephalomyelitis. Ann. N. Y. Acad. Sci. 436: 98–102. [DOI] [PubMed] [Google Scholar]
  • 60. Ludwin, S. K. 1978. Central nervous system demyelination and remyelination in the mouse. An ultrastructural study of cuprizone toxicity. Lab. Invest. 39: 597–612. [PubMed] [Google Scholar]
  • 61. Dal. Canto, M. C. & Barbano R. L.. 1984. Remyelination during remission in Theiler's virus infection. Am. J. Pathol. 116: 30–45. [PMC free article] [PubMed] [Google Scholar]
  • 62. Raine, C. S. & Traugott U.. 1983. Chronic relapsing experimental autoimmune encephalomyelitis: Ultrastructure of the central nervous system of animals treated with combinations of myelin components. Lab. Invest. 48: 275–284. [PubMed] [Google Scholar]
  • 63. Lang, W. , Wiley C. & Lampert P.. 1985. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components. J. Neuroimmunol. 9: 109–113. [DOI] [PubMed] [Google Scholar]
  • 64. Rodriguez, M. , Lennon V. A., Benveniste E. N. & Merrill J. E.. 1987. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J. Neuropathol. Exp. Neurol. 46: 84–95. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the New York Academy of Sciences are provided here courtesy of Wiley

RESOURCES